Malignant Mesothelioma Effusions Are Infiltrated by CD3 + T Cells Highly Expressing PD-L1 and the PD-L1 + Tumor Cells within These Effusions Are Susceptible to ADCC by the Anti–PD-L1 Antibody Avelumab-Reference-Cited by-同舟云学术

Malignant Mesothelioma Effusions Are Infiltrated by CD3 + T Cells Highly Expressing PD-L1 and the PD-L1 + Tumor Cells within These Effusions Are Susceptible to ADCC by the Anti–PD-L1 Antibody Avelumab

Published:2016-11 Issue:11 Volume:11 Page:1993-2005
ISSN:1556-0864
Container-title:Journal of Thoracic Oncology
language:en
Short-container-title:Journal of Thoracic Oncology

Author:

Khanna Swati,Thomas Anish,Abate-Daga Daniel,Zhang Jingli,Morrow Betsy,Steinberg Seth M.,Orlandi Augusto,Ferroni Patrizia,Schlom Jeffrey,Guadagni Fiorella,Hassan Raffit

Funder

Center for Cancer Research

National Cancer Institute

National Institutes of Health

Publisher

Elsevier BV

Subject

Pulmonary and Respiratory Medicine,Oncology

Reference39 articles.

1. Advances in malignant mesothelioma;Robinson;N Engl J Med,2005

2. Malignant pleural mesothelioma;Boutin;Eur Respir J,1998

3. Phase III study of pemetrexed in combination with cisplatin versus cisplatin alone in patients with malignant pleural mesothelioma;Vogelzang;J Clin Oncol,2003